Skip to main content
MREO logo

MREO · Mereo BioPharma Group plc · Held by Funds

Track MREO — free
$0.29 0.00 (-1.68%)
Market Cap
$46.50M
Shares
159.69M
Volume · Oct 22 209.97K Avg daily vol (3M) 3.99M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of MREO by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.37% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.06% 92,534
Index ETFs 0.31% 494,603
Active ETFs 0.00% 0
Active funds 0.01% 14,500
Unclassified 0.00% 0
All registered funds 0.38% 601,637
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding MREO

4 fund positions
Fund Balance Value % of Fund Open
Showing 1–4 of 4 positions
Key facts CIK 1719714 CUSIP 589492107 13F (30d) 2 filings 2 filers Visit website Investor relations